Skip to content

The effect of anterior cruciate ligament injury on skeletal muscle function, contractile proteins and inflammation

Skeletal muscle biopsy to evaluate Na+, K+, and ATPase content in young ACL injured participants

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000157774
Enrollment
12
Registered
2013-02-08
Start date
2013-03-04
Completion date
2014-12-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Damage to the Anterior cruciate ligament (ACL), a ligament vital for the stability of the knee joint, affects the ability to perform daily activities and physical exercise. The reduced physical activity caused by knee injury can cause changes in the muscle of the leg, causing decreased muscle strength, size and endurance. This study proposes to test the effect of ACL injury (knee injury) on muscle on a microscopic or molecular level, and investigate how such molecular changes in the muscle can affect knee function. A second aim of the study is to investigate the role of inflammation in the knee joint and how it affects leg strength and physical activity levels. This will be achieved by measuring strength, balance, physical activity levels, and muscle samples in patients undergoing ACL reconstructive surgery compared to a matched control group. It is hypothesized that after acute ACL trauma, functional changes in quality of life and muscle function of the injured limb will be associated with adverse changes in knee extensor muscle contractility on a biochemical level.

Interventions

No drug intervention involved. Muscle sample taken via muscle biopsy with a Bergstrom needle from the vastus lateralis of both injured and uninjured legs of patients undergoing ACL reconstructive surgery. The biopsy procedure takes less than 5 minutes on each leg.

Sponsors

Victoria University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

ACL group: 1. Scheduled for ACL reconstructive surgery. 2. Between 18-35 years of age 3. BMI <30 Control Group: 1. Free from lower limb injury 2. Between 18-35 years of age 3. BMI <30

Exclusion criteria

ACL group: Not between 18-35 years of age. Any metabolic or cardiovascular diseases which impact on physical activity prior to ACL injury. Control group Not between 18-35 years of age Any metabolic or cardiovascular diseases which impact on physical activity levels Recent lower limb joint injury

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026